Smith, Moore & Co’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,826
Closed -$128K 443
2023
Q4
$128K Sell
11,826
-31,751
-73% -$304K 0.02% 401
2023
Q3
$430K Sell
43,577
-265
-0.6% -$2.76K 0.06% 262
2023
Q2
$438K Sell
43,842
-10,626
-20% -$101K 0.06% 266
2023
Q1
$524K Sell
54,468
-45,421
-45% -$504K 0.07% 232
2022
Q4
$1.11M Sell
99,889
-11,980
-11% -$125K 0.15% 124
2022
Q3
$953K Sell
111,869
-6,629
-6% -$65.2K 0.14% 125
2022
Q2
$1.24M Buy
118,498
+2,435
+2% +$26.7K 0.19% 109
2022
Q1
$1.26M Buy
116,063
+1,479
+1% +$19.5K 0.17% 118
2021
Q4
$1.55M Sell
114,584
-4,798
-4% -$64.1K 0.22% 87
2021
Q3
$1.62M Buy
119,382
+35,344
+42% +$501K 0.25% 75
2021
Q2
$1.2M Buy
84,038
+519
+0.6% +$7.51K 0.18% 107
2021
Q1
$1.17M Buy
+83,519
New +$1.36M 0.19% 109

Other funds holding VTRS

Smith, Moore & Co's VTRS Position: Q1 2024 in Review

Smith, Moore & Co sold out of Viatris (VTRS) in Q1 2024, closing a stake of 11,826 shares — an estimated $128K sold.

Smith, Moore & Co first reported a position in VTRS in Q1 2021 and held it in 12 quarters. The position peaked at $1.62M in Q3 2021. 1,008 funds tracked by Wall St. Rank hold VTRS as of Q1 2024.

  • Smith, Moore & Co reported no remaining Viatris position as of Q1 2024 after selling out during the quarter.
  • Smith, Moore & Co sold 11,826 Viatris shares in Q1 2024, an estimated $128K.
  • Smith, Moore & Co first reported a position in Viatris in Q1 2021 and held it in 12 quarters.
  • Smith, Moore & Co's Viatris position peaked at $1.62M in Q3 2021.
  • 1,008 funds tracked by Wall St. Rank held Viatris as of Q1 2024.

Based on Smith, Moore & Co's 13F filing for Q1 2024, filed 13 May 2024.